Mortality Risk at 30 Days in STEMI
Risk Factor | Points |
|---|---|
Age ≥ 75 years | 3 |
Age 65–74 years | 2 |
Diabetes mellitus, hypertension, or angina | 1 |
Systolic blood pressure < 100 mm Hg | 3 |
Heart rate > 100 beats/minute | 2 |
Killip class II–IV | 2 |
Weight < 67 kg | 1 |
Anterior ST-elevation or left branch bundle block | 1 |
Time to treatment > 4 hours | 1 |
Total points possible | 0–14 |
Risk | |
Total Points | Mortality Rate at 30 Days (%) |
0 | 0.8 |
1 | 1.6 |
2 | 2.2 |
3 | 4.4 |
4 | 7.3 |
5 | 12.4 |
6 | 16.1 |
7 | 23.4 |
8 | 26.8 |
> 8 | 35.9 |
MI = myocardial infarction; STEMI = ST-segment elevation MI; TIMI = thrombolysis in MI. | |
Based on Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102 (17):2031-2037. doi:10.1161/01.cir.102.17.2031 and Rao SV, O'Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;151(13):e771-e862. doi:10.1161/CIR.0000000000001309. | |
